The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Cancer Pain-Global Market Insights and Sales Trends 2025
Synopsis
Cancer pain is one of the most common symptoms in cancer patients. Pain can be caused by cancer, cancer treatment, or a combination of factors.
The global Cancer Pain market size is expected to reach US$ 8568 million by 2029, growing at a CAGR of 5.2% from 2023 to 2029. The market is mainly driven by the significant applications of Cancer Pain in various end use industries. The expanding demands from the Radiotherapy, Chemotherapy, Hormone Therapy and Others, are propelling Cancer Pain market. Opioids, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Non-Steroidal Anti-Inflammatory Drugs segment is estimated at % CAGR for the next seven-year period.
The growth of the global cancer pain market is mainly due to the increasing prevalence of cancer; rising geriatric population; rising healthcare expenditure; and increasing investment in research and development activities by various healthcare companies. Due to aging effects and genetic mutations, older people are more prone to various types of cancer, such as lung cancer, bladder cancer, kidney cancer, melanoma, etc. According to the National Cancer Institute, the median age at diagnosis is 61 for breast cancer, 68 for colorectal cancer, 70 for lung cancer and 66 for prostate cancer. However, side effects associated with drugs used in cancer pain treatment, such as drug tolerance, drug dependence, urinary retention, sleep disturbance, cognitive impairment, etc., are expected to restrain the growth of the cancer pain market over the forecast period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cancer Pain, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cancer Pain market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cancer Pain market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cancer Pain sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cancer Pain covered in this report include BioDelivery Science, ProStrakan Group, Teva pharmaceuticals, Eli-Lilly, Grunenthal Group, GW Pharmaceuticals, Johnson＆Johnson, Meda Pharmaceuticals and Orexo, etc.
The global Cancer Pain market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BioDelivery Science
ProStrakan Group
Teva pharmaceuticals
Eli-Lilly
Grunenthal Group
GW Pharmaceuticals
Johnson＆Johnson
Meda Pharmaceuticals
Orexo
Sanofi
WEX Pharmaceuticals
Global Cancer Pain market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cancer Pain market, Segment by Type:
Opioids
Non-Steroidal Anti-Inflammatory Drugs
Others
Global Cancer Pain market, by Application
Radiotherapy
Chemotherapy
Hormone Therapy
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cancer Pain companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Cancer pain is one of the most common symptoms in cancer patients. Pain can be caused by cancer, cancer treatment, or a combination of factors.
The global Cancer Pain market size is expected to reach US$ 8568 million by 2029, growing at a CAGR of 5.2% from 2023 to 2029. The market is mainly driven by the significant applications of Cancer Pain in various end use industries. The expanding demands from the Radiotherapy, Chemotherapy, Hormone Therapy and Others, are propelling Cancer Pain market. Opioids, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Non-Steroidal Anti-Inflammatory Drugs segment is estimated at % CAGR for the next seven-year period.
The growth of the global cancer pain market is mainly due to the increasing prevalence of cancer; rising geriatric population; rising healthcare expenditure; and increasing investment in research and development activities by various healthcare companies. Due to aging effects and genetic mutations, older people are more prone to various types of cancer, such as lung cancer, bladder cancer, kidney cancer, melanoma, etc. According to the National Cancer Institute, the median age at diagnosis is 61 for breast cancer, 68 for colorectal cancer, 70 for lung cancer and 66 for prostate cancer. However, side effects associated with drugs used in cancer pain treatment, such as drug tolerance, drug dependence, urinary retention, sleep disturbance, cognitive impairment, etc., are expected to restrain the growth of the cancer pain market over the forecast period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cancer Pain, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cancer Pain market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cancer Pain market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cancer Pain sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cancer Pain covered in this report include BioDelivery Science, ProStrakan Group, Teva pharmaceuticals, Eli-Lilly, Grunenthal Group, GW Pharmaceuticals, Johnson＆Johnson, Meda Pharmaceuticals and Orexo, etc.
The global Cancer Pain market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BioDelivery Science
ProStrakan Group
Teva pharmaceuticals
Eli-Lilly
Grunenthal Group
GW Pharmaceuticals
Johnson＆Johnson
Meda Pharmaceuticals
Orexo
Sanofi
WEX Pharmaceuticals
Global Cancer Pain market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cancer Pain market, Segment by Type:
Opioids
Non-Steroidal Anti-Inflammatory Drugs
Others
Global Cancer Pain market, by Application
Radiotherapy
Chemotherapy
Hormone Therapy
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cancer Pain companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Cancer Pain
1.1 Cancer Pain Market Overview
1.1.1 Cancer Pain Product Scope
1.1.2 Cancer Pain Market Status and Outlook
1.2 Global Cancer Pain Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Cancer Pain Market Size by Region (2018-2029)
1.4 Global Cancer Pain Historic Market Size by Region (2018-2023)
1.5 Global Cancer Pain Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Cancer Pain Market Size (2018-2029)
1.6.1 North America Cancer Pain Market Size (2018-2029)
1.6.2 Europe Cancer Pain Market Size (2018-2029)
1.6.3 Asia-Pacific Cancer Pain Market Size (2018-2029)
1.6.4 Latin America Cancer Pain Market Size (2018-2029)
1.6.5 Middle East & Africa Cancer Pain Market Size (2018-2029)
2 Cancer Pain Market by Type
2.1 Introduction
2.1.1 Opioids
2.1.2 Non-Steroidal Anti-Inflammatory Drugs
2.1.3 Others
2.2 Global Cancer Pain Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Cancer Pain Historic Market Size by Type (2018-2023)
2.2.2 Global Cancer Pain Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Cancer Pain Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Cancer Pain Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Cancer Pain Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Cancer Pain Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Cancer Pain Revenue Breakdown by Type (2018-2029)
3 Cancer Pain Market Overview by Application
3.1 Introduction
3.1.1 Radiotherapy
3.1.2 Chemotherapy
3.1.3 Hormone Therapy
3.1.4 Others
3.2 Global Cancer Pain Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Cancer Pain Historic Market Size by Application (2018-2023)
3.2.2 Global Cancer Pain Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Cancer Pain Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Cancer Pain Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Cancer Pain Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Cancer Pain Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Cancer Pain Revenue Breakdown by Application (2018-2029)
4 Cancer Pain Competition Analysis by Players
4.1 Global Cancer Pain Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cancer Pain as of 2022)
4.3 Date of Key Players Enter into Cancer Pain Market
4.4 Global Top Players Cancer Pain Headquarters and Area Served
4.5 Key Players Cancer Pain Product Solution and Service
4.6 Competitive Status
4.6.1 Cancer Pain Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 BioDelivery Science
5.1.1 BioDelivery Science Profile
5.1.2 BioDelivery Science Main Business
5.1.3 BioDelivery Science Cancer Pain Products, Services and Solutions
5.1.4 BioDelivery Science Cancer Pain Revenue (US$ Million) & (2018-2023)
5.1.5 BioDelivery Science Recent Developments
5.2 ProStrakan Group
5.2.1 ProStrakan Group Profile
5.2.2 ProStrakan Group Main Business
5.2.3 ProStrakan Group Cancer Pain Products, Services and Solutions
5.2.4 ProStrakan Group Cancer Pain Revenue (US$ Million) & (2018-2023)
5.2.5 ProStrakan Group Recent Developments
5.3 Teva pharmaceuticals
5.3.1 Teva pharmaceuticals Profile
5.3.2 Teva pharmaceuticals Main Business
5.3.3 Teva pharmaceuticals Cancer Pain Products, Services and Solutions
5.3.4 Teva pharmaceuticals Cancer Pain Revenue (US$ Million) & (2018-2023)
5.3.5 Eli-Lilly Recent Developments
5.4 Eli-Lilly
5.4.1 Eli-Lilly Profile
5.4.2 Eli-Lilly Main Business
5.4.3 Eli-Lilly Cancer Pain Products, Services and Solutions
5.4.4 Eli-Lilly Cancer Pain Revenue (US$ Million) & (2018-2023)
5.4.5 Eli-Lilly Recent Developments
5.5 Grunenthal Group
5.5.1 Grunenthal Group Profile
5.5.2 Grunenthal Group Main Business
5.5.3 Grunenthal Group Cancer Pain Products, Services and Solutions
5.5.4 Grunenthal Group Cancer Pain Revenue (US$ Million) & (2018-2023)
5.5.5 Grunenthal Group Recent Developments
5.6 GW Pharmaceuticals
5.6.1 GW Pharmaceuticals Profile
5.6.2 GW Pharmaceuticals Main Business
5.6.3 GW Pharmaceuticals Cancer Pain Products, Services and Solutions
5.6.4 GW Pharmaceuticals Cancer Pain Revenue (US$ Million) & (2018-2023)
5.6.5 GW Pharmaceuticals Recent Developments
5.7 Johnson＆Johnson
5.7.1 Johnson＆Johnson Profile
5.7.2 Johnson＆Johnson Main Business
5.7.3 Johnson＆Johnson Cancer Pain Products, Services and Solutions
5.7.4 Johnson＆Johnson Cancer Pain Revenue (US$ Million) & (2018-2023)
5.7.5 Johnson＆Johnson Recent Developments
5.8 Meda Pharmaceuticals
5.8.1 Meda Pharmaceuticals Profile
5.8.2 Meda Pharmaceuticals Main Business
5.8.3 Meda Pharmaceuticals Cancer Pain Products, Services and Solutions
5.8.4 Meda Pharmaceuticals Cancer Pain Revenue (US$ Million) & (2018-2023)
5.8.5 Meda Pharmaceuticals Recent Developments
5.9 Orexo
5.9.1 Orexo Profile
5.9.2 Orexo Main Business
5.9.3 Orexo Cancer Pain Products, Services and Solutions
5.9.4 Orexo Cancer Pain Revenue (US$ Million) & (2018-2023)
5.9.5 Orexo Recent Developments
5.10 Sanofi
5.10.1 Sanofi Profile
5.10.2 Sanofi Main Business
5.10.3 Sanofi Cancer Pain Products, Services and Solutions
5.10.4 Sanofi Cancer Pain Revenue (US$ Million) & (2018-2023)
5.10.5 Sanofi Recent Developments
5.11 WEX Pharmaceuticals
5.11.1 WEX Pharmaceuticals Profile
5.11.2 WEX Pharmaceuticals Main Business
5.11.3 WEX Pharmaceuticals Cancer Pain Products, Services and Solutions
5.11.4 WEX Pharmaceuticals Cancer Pain Revenue (US$ Million) & (2018-2023)
5.11.5 WEX Pharmaceuticals Recent Developments
6 North America
6.1 North America Cancer Pain Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Cancer Pain Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Cancer Pain Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Cancer Pain Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Cancer Pain Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Cancer Pain Market Dynamics
11.1 Cancer Pain Industry Trends
11.2 Cancer Pain Market Drivers
11.3 Cancer Pain Market Challenges
11.4 Cancer Pain Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
